Antibody-Dependent Cell-Mediated Cytotoxicity Effector-Enhanced EphA2 Agonist Monoclonal Antibody Demonstrates Potent Activity against Human Tumors
EphA2 is a receptor tyrosine kinase that has been shown to be overexpressed in a variety of human tumor types. Previous studies demonstrated that agonist monoclonal antibodies targeting EphA2 induced the internalization and degradation of the receptor, thereby abolishing its oncogenic effects. In th...
Main Authors: | Elizabeth M. Bruckheimer, Christine A. Fazenbaker, Sandra Gallagher, Kathy Mulgrew, Stacy Fuhrmann, Karen T. Coffman, William Walsh, Shannon Ready, Kim Cook, Melissa Damschroder, Michael Kinch, Peter A. Kiener, Rob Woods, Changshou Gao, William Dall'Acqua, Herren Wu, Steven Coats |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558609801085 |
Similar Items
-
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
by: Carolin Offenhäuser, et al.
Published: (2018-12-01) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
by: Malgorzata Gajdzis, et al.
Published: (2020-09-01) -
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF
by: Miriam S. Hohmann, et al.
Published: (2021-06-01) -
Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic
by: Walid Kamoun, et al.
Published: (2020-10-01) -
The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
by: Jae Min Shin, et al.
Published: (2023-02-01)